Certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech Limited has submitted a quarterly certificate to BSE as required under SEBI's Depositories and Participants Regulations, 2018 for the period ending 30 September 2025. The certificate, issued by the company's Registrar and Share Transfer Agent XL Softech Systems Ltd., confirms that all share certificates received for dematerialization during the quarter were properly verified, processed (accepted or rejected), and that cancelled physical certificates were mutilated within the 30-day deadline. The letter was signed by Namrata Randeri, the Insolvency Professional handling the company, indicating the firm remains under the Corporate Insolvency Resolution Process (CIRP).
This is a routine regulatory compliance filing with no impact on share price or shareholder value. It simply confirms the RTA processed dematerialization requests correctly during the quarter, and signals that the company's CIRP proceedings are still ongoing.